Results 271 to 280 of about 784,460 (315)
Some of the next articles are maybe not open access.
Circulating tumor markers in gynecological tumors
Current Opinion in Oncology, 1996The correct use of tumor markers in patients with gynecological cancers can make an impact on management of the disease. Their value in screening for ovarian cancer cannot be recommended outside trials. Increased levels of various markers give prognostic information that could alter therapy for patients with early ovarian or cervical carcinoma.
openaire +2 more sources
Acta medica Iugoslavica, 1991
A combination of 2 or 3 tumor markers was determined in the serum of 478 patients with malignant tumors. In 195 out of 213 patients with differentiated thyroid cancer and without relapse or metastases, the Tg concentration has undetectable. In 9 patients with nonfunctioning thyroid metastases the Tg level was correlated with the progress of the disease
Kusić, Zvonko +5 more
openaire +2 more sources
A combination of 2 or 3 tumor markers was determined in the serum of 478 patients with malignant tumors. In 195 out of 213 patients with differentiated thyroid cancer and without relapse or metastases, the Tg concentration has undetectable. In 9 patients with nonfunctioning thyroid metastases the Tg level was correlated with the progress of the disease
Kusić, Zvonko +5 more
openaire +2 more sources
Tumoral markers in tumors of the pineal region
Neurochirurgie, 2015In cases of pineal tumors, a germ cell tumor should always be suspected. As some of them are secreting tumors, tumoral markers (AFP and/or hGC) are an important part of the diagnostic process. Their positivity either in the serum and/or in the cerebrospinal fluid may lead to an accurate diagnosis, avoiding a potentially dangerous surgical biopsy ...
openaire +2 more sources
Photoelectrochemical biosensing platforms for tumor marker detection
Coordination Chemistry Reviews, 2022Zhen Zhang, Zichao Chen
exaly
Brain and other central nervous system tumor statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021, Jill Barnholtz-Sloan, Carol Kruchko
exaly
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Heather A Parsons +2 more
exaly

